Exon 2 was targeted with three shRNA guide sequences (5'-ACACTATCTGGAGTCACTTA-3', 5'-CTACCTAGTAGCCAAGACTG-3', 5'-AGTCATCTGGAAGATGGTGC-3') using CRISPR/Cas9 technology. One founder mouse presented with an insertion of a G nucleotide in exon 2 (c.301_302insG), causing a frameshift and premature termination. (J:291290)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count